GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The following is a summary of “Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...

Of 200 countries studied by experts by the World Health Organization, in the period between 1990 and 2022 - the most recent ...

China: A recent real-world study has revealed promising benefits from combining sodium-glucose co-transporter 2 inhibitors ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

The study predicts devastating trends at the population level.

Spare tire got you feeling deflated? A functional medicine specialist says a hormonal imbalance could be to blame for your ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE).